Tolerability and efficacy of glycemic control with saxagliptin in older patients (aged ≥ 65 years) with inadequately controlled type 2 diabetes mellitus

PURPOSE: To assess safety and efficacy of saxagliptin in older patients with type 2 diabetes mellitus (T2DM). PATIENTS AND METHODS: This was a post hoc analysis of pooled data from older patients (≥65 years of age) from five 24-week phase III trials: three studies of saxagliptin versus placebo as an...

Descripción completa

Detalles Bibliográficos
Autores principales: Karyekar, Chetan S, Ravichandran, Shoba, Allen, Elsie, Fleming, Douglas, Frederich, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632630/
https://www.ncbi.nlm.nih.gov/pubmed/23626461
http://dx.doi.org/10.2147/CIA.S41246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632630/
https://www.ncbi.nlm.nih.gov/pubmed/23626461
http://dx.doi.org/10.2147/CIA.S41246

Ejemplares similares